CTKB | tickerfilter.com

Fundamental analysis

36%

Profitability 35%

Dept financing 23%

Liquidity 75%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-8.28%

1 Month

-2.48%

3 Months

-14.46%

6 Months

27.81%

1 Year

8.00%

2 Year

-35.62%

Key data

Stock price

$4.32

P/E Ratio

0.00

DAY RANGE

$4.28 - $4.65

EPS

N/A

52 WEEK RANGE

$2.37 - $6.18

52 WEEK CHANGE

$7.73

MARKET CAP

645.717 M

YIELD

N/A

SHARES OUTSTANDING

128.550 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-07-2025

BETA

1.63

PUBLIC FLOAT

AVERAGE 10 VOLUME

$822,607

AVERAGE 30 VOLUME

$859,085

Company detail

CEO: Wen B. Jiang
Region: US
Website: cytekbio.com
Employees: 500
IPO year: 2021

Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Cytek Biosciences, Inc. provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also provides reagents and kits, including cFluor reagents.

CTKB - Cytek Biosciences, Inc.